Infusystem Holdings Inc Quick Ratio (INFU) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Infusystem Holdings Inc  (NYSEAMER: INFU)

Infusystem Holdings Inc's Quick Ratio

INFU's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Infusystem Holdings Inc's Cash & cash equivalent grew by 844.81 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Infusystem Holdings Inc's Quick Ratio to 0.51, above Infusystem Holdings Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 184 other companies have achieved higher Quick Ratio than Infusystem Holdings Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3143 to 3878.

Explain Quick Ratio?
How much Cash & cash equivalents INFU´s has?
What are INFU´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/INFU/financial-strength
https://api.csimarket.com/api/v1/companies/INFU/fundamentals
https://api.csimarket.com/api/v1/companies/INFU/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
INFU Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change -4.51 %
Y / Y Cash & cash equivalent Change 853.72 %
Quick Ratio MRQ 0.51
INFU's Total Ranking # 3878
Seq. Current Liabilities Change 16.82 %
Seq. Cash & cash equivalent Change 844.81 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 185
Healthcare Sector # 856
Overall Market # 3878


Quick Ratio Statistics
High Average Low
0.63 0.1 0
(Dec 31 2010)   (Mar 31 2017)




Financial Statements
Infusystem Holdings Inc's Current Liabilities $ 18 Millions Visit INFU's Balance sheet
Infusystem Holdings Inc's Cash & cash equivalent $ 9 Millions Visit INFU's Balance sheet
Source of INFU's Sales Visit INFU's Sales by Geography


Cumulative Infusystem Holdings Inc's Quick Ratio

INFU's Quick Ratio for the trailling 12 Months

INFU Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 3.35 %
Y / Y Cash & cash equivalent TTM Growth 314.35 %
Quick Ratio TTM 0.22
Total Ranking TTM # 3320
Seq. Current Liabilities TTM Growth -1.18 %
Seq. Cash & cash equivalent TTM Growth 113.06 %


On the trailing twelve months basis INFU Cash & cash equivalent more than doubled by 853.72 % in Q3 2026 year on year, while Current Liabilities increased to $18 millions, this led to increase in in Infusystem Holdings Inc's Quick Ratio to 0.22, above INFU average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Infusystem Holdings Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3019 to 4138.

Explain Quick Ratio?
How much Cash & cash equivalents INFU´s has?
What are INFU´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 912
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
0.23 0.09 0.01
(Dec 31 2018)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Sanara Medtech Inc   1.09 $ 17.788  Millions$ 16.282  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Myomo Inc   0.93 $ 11.946  Millions$ 12.902  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Lucid Diagnostics Inc   0.83 $ 17.993  Millions$ 21.646  Millions
Seastar Medical Holding Corp  0.82 $ 3.989  Millions$ 4.841  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Qhslab Inc   0.77 $ 0.190  Millions$ 0.247  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.69 $ 8.124  Millions$ 11.778  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions

Date modified: 2026-11-10T10:00:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.